135 related articles for article (PubMed ID: 2859067)
1. Schizophrenia with good and poor outcome. I: Early clinical features, response to neuroleptics and signs of organic dysfunction.
Kolakowska T; Williams AO; Ardern M; Reveley MA; Jambor K; Gelder MG; Mandelbrote BM
Br J Psychiatry; 1985 Mar; 146():229-39. PubMed ID: 2859067
[TBL] [Abstract][Full Text] [Related]
2. Schizophrenia with good and poor outcome. III: Neurological 'soft' signs, cognitive impairment and their clinical significance.
Kolakowska T; Williams AO; Jambor K; Ardern M
Br J Psychiatry; 1985 Apr; 146():348-57. PubMed ID: 4016437
[TBL] [Abstract][Full Text] [Related]
3. Schizophrenia with good and poor outcome. II: Cerebral ventricular size and its clinical significance.
Williams AO; Reveley MA; Kolakowska T; Ardern M; Mandelbrote BM
Br J Psychiatry; 1985 Mar; 146():239-46. PubMed ID: 2859068
[TBL] [Abstract][Full Text] [Related]
4. Within-individual variation in steady state plasma levels of different neuroleptics and prolactin.
McCreadie RG; Mackie M; Wiles DH; Jorgensen A; Hansen V; Menzies C
Br J Psychiatry; 1984 Jun; 144():625-9. PubMed ID: 6146373
[TBL] [Abstract][Full Text] [Related]
5. Predictors of early stable symptomatic remission after an exacerbation of schizophrenia: the significance of symptoms, neuropsychological performance and cognitive biases.
Andreou C; Roesch-Ely D; Veckenstedt R; Bohn F; Aghotor J; Köther U; Pfueller U; Moritz S
Psychiatry Res; 2013 Dec; 210(3):729-34. PubMed ID: 23998362
[TBL] [Abstract][Full Text] [Related]
6. Differential cognitive performances between schizophrenic responders and non-responders to antipsychotics: correlation with course of the illness, psychopathology, attitude to the treatment and antipsychotics doses.
de Bartolomeis A; Balletta R; Giordano S; Buonaguro EF; Latte G; Iasevoli F
Psychiatry Res; 2013 Dec; 210(2):387-95. PubMed ID: 23910239
[TBL] [Abstract][Full Text] [Related]
7. Clinical and demographic correlates of neuroleptic response.
Seeman MV
Can J Psychiatry; 1985 Jun; 30(4):243-5. PubMed ID: 2861886
[TBL] [Abstract][Full Text] [Related]
8. Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder.
Robinson DG; Woerner MG; Alvir JM; Geisler S; Koreen A; Sheitman B; Chakos M; Mayerhoff D; Bilder R; Goldman R; Lieberman JA
Am J Psychiatry; 1999 Apr; 156(4):544-9. PubMed ID: 10200732
[TBL] [Abstract][Full Text] [Related]
9. Trajectories and antecedents of treatment response over time in early-episode psychosis.
Levine SZ; Rabinowitz J
Schizophr Bull; 2010 May; 36(3):624-32. PubMed ID: 18849294
[TBL] [Abstract][Full Text] [Related]
10. Premorbid adjustment in first episode schizophrenia and schizoaffective disorders: a comparison of social and academic domains.
Norman RM; Malla AK; Manchanda R; Townsend L
Acta Psychiatr Scand; 2005 Jul; 112(1):30-9. PubMed ID: 15952943
[TBL] [Abstract][Full Text] [Related]
11. [Minor neurological and physical anomalies in patients with first-episode psychosis].
Mhalla A; Boussaïd N; Gassab L; Gaha L; Mechri A
Encephale; 2013 Jun; 39(3):149-54. PubMed ID: 23095597
[TBL] [Abstract][Full Text] [Related]
12. The Scottish First Episode Schizophrenia Study. II. Treatment: pimozide versus flupenthixol. The Scottish Schizophrenia Research Group.
Br J Psychiatry; 1987 Mar; 150():334-8. PubMed ID: 2889495
[TBL] [Abstract][Full Text] [Related]
13. Neuropsychological dysfunction in antipsychotic-naive first-episode unipolar psychotic depression.
Hill SK; Keshavan MS; Thase ME; Sweeney JA
Am J Psychiatry; 2004 Jun; 161(6):996-1003. PubMed ID: 15169687
[TBL] [Abstract][Full Text] [Related]
14. Untreated initial psychosis: relation to cognitive deficits and brain morphology in first-episode schizophrenia.
Ho BC; Alicata D; Ward J; Moser DJ; O'Leary DS; Arndt S; Andreasen NC
Am J Psychiatry; 2003 Jan; 160(1):142-8. PubMed ID: 12505813
[TBL] [Abstract][Full Text] [Related]
15. Ex uno multi: subtyping the schizophrenic syndrome.
Jeste DV; Kleinman JE; Potkin SG; Luchins DJ; Weinberger DR
Biol Psychiatry; 1982 Feb; 17(2):199-222. PubMed ID: 6122474
[TBL] [Abstract][Full Text] [Related]
16. Predictors of acute treatment response in patients with a first episode of non-affective psychosis: sociodemographics, premorbid and clinical variables.
Crespo-Facorro B; Pelayo-Terán JM; Pérez-Iglesias R; Ramírez-Bonilla M; Martínez-García O; Pardo-García G; Vázquez-Barquero JL
J Psychiatr Res; 2007 Oct; 41(8):659-66. PubMed ID: 16797591
[TBL] [Abstract][Full Text] [Related]
17. Cortical atrophy and white matter density in the brains of schizophrenics and clinical response to neuroleptics.
Smith RC; Baumgartner R; Ravichandran GK; Largen J; Calderon M; Burd A; Mauldin M
Acta Psychiatr Scand; 1987 Jan; 75(1):11-9. PubMed ID: 2883814
[TBL] [Abstract][Full Text] [Related]
18. Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients.
Szymanski S; Lieberman JA; Alvir JM; Mayerhoff D; Loebel A; Geisler S; Chakos M; Koreen A; Jody D; Kane J
Am J Psychiatry; 1995 May; 152(5):698-703. PubMed ID: 7726309
[TBL] [Abstract][Full Text] [Related]
19. Lowest effective dose of depot neuroleptics.
Hoencamp E; Haffmans PJ; Jansen GS
Br J Psychiatry; 1992 Mar; 160():422-3. PubMed ID: 1348655
[No Abstract] [Full Text] [Related]
20. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
